Kedar Kirtane1 article listing Kedar Kirtane in Nature Communications, indexed by Paperzzz from Crossref and OSF.MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial Nature Communications